Imigra 10 mg (Capsule)
Unit Price: ৳ 5.02 (5 x 10: ৳ 251.00)
Strip Price: ৳ 50.20
Medicine Details
Category | Details |
---|---|
Generic | Flunarizine |
Company | Navana pharmaceuticals ltd |
Also available as |
Title
- Imigra
Categories
- Medicine
- Pharmaceuticals
- Healthcare
Description
- Prophylaxis of classic (with aura) or common (without aura) migraine
- Symptomatic treatment of vestibular vertigo
- Peripheral Vascular Disease (PVD) treatment
- Motion sickness treatment
- Refractory epilepsy resistant to conventional antiepileptic therapy
Color Options
- N/A
Dimensions
- N/A
Functions
- Prophylaxis of classic and common migraine
- Symptomatic treatment of vestibular vertigo
- Peripheral Vascular Disease (PVD) treatment
- Motion sickness treatment
- Refractory epilepsy resistant to conventional antiepileptic therapy
Materials
- Flunarizine
Technical Specifications
- Selective calcium channel antagonist
- Binds at an affinity of 99% to plasma protein
Design Elements
- N/A
Usability Features
- Drowsiness and/or fatigue may occur
- May lead to weight gain and/or increased appetite
- May reveal Parkinsonism especially in predisposed patients such as the elderly
- Not suited for aborting a migraine attack
- Cautioned against driving motor vehicles or performing other potentially hazardous tasks
- Storage temperature below 30°C
Dosage & Administration
- Starting Dose: 10 mg at night in patients less than 65 years of age and 5 mg daily in patients older than 65 years
- Maintenance Treatment: Dose should be decreased to 5 days treatment at the same daily dose with two successive medicine-free days every week
- Peripheral Vascular disease: 10 mg twice daily, up to 30 mg per day if required
- Vertigo & motion sickness: 10-20 mg daily for adults and 5 mg daily for children (>40 kg)
- Epileptic seizure: 15-20 mg daily in adults and 5 to 10 mg daily for children as add-on therapy
Interaction
- Galactorrhoea has been reported in few women on oral contraceptives within the first two months of Imigra treatment
- Hepatic enzyme inducers such as Carbamazepine and Phenytoin may interact with Imigra by increasing its metabolism
Contraindications
- Hypersensitivity to Flunarizine
- History of depressive illness
- Pre-existing symptoms of Parkinson's disease or other extrapyramidal disorders
Side Effects
- Drowsiness and/or fatigue
- Weight gain and/or increased appetite
- Adverse experiences reported during chronic treatment with Imigra: depression, extrapyramidal symptoms, heartburn, nausea, gastralgia, insomnia, anxiety, galactorrhoea, dry mouth, muscle ache, skin rash
Pregnancy & Lactation
- Safety not established
Precautions & Warnings
- May lead to drowsiness aggravated by simultaneous intake of alcohol or other central nervous system depressants
- Not suited for aborting a migraine attack
- May reveal Parkinsonism especially in predisposed patients such as the elderly
- Cautioned against driving motor vehicles or performing other potentially hazardous tasks
- Used with caution in predisposed patients such as the elderly
Therapeutic Class
- Miscellaneous prophylactic migraine preparations
Storage Conditions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children